"Immunosuppressive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
| Descriptor ID |
D007166
|
| MeSH Number(s) |
D27.505.696.477.656
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunosuppressive Agents".
Below are MeSH descriptors whose meaning is more specific than "Immunosuppressive Agents".
This graph shows the total number of publications written about "Immunosuppressive Agents" by people in this website by year, and whether "Immunosuppressive Agents" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 21 | 10 | 31 |
| 1996 | 38 | 21 | 59 |
| 1997 | 27 | 17 | 44 |
| 1998 | 40 | 15 | 55 |
| 1999 | 32 | 19 | 51 |
| 2000 | 33 | 20 | 53 |
| 2001 | 35 | 29 | 64 |
| 2002 | 35 | 27 | 62 |
| 2003 | 49 | 35 | 84 |
| 2004 | 42 | 22 | 64 |
| 2005 | 54 | 38 | 92 |
| 2006 | 47 | 45 | 92 |
| 2007 | 49 | 50 | 99 |
| 2008 | 59 | 55 | 114 |
| 2009 | 57 | 48 | 105 |
| 2010 | 76 | 58 | 134 |
| 2011 | 67 | 56 | 123 |
| 2012 | 63 | 47 | 110 |
| 2013 | 58 | 45 | 103 |
| 2014 | 66 | 49 | 115 |
| 2015 | 56 | 62 | 118 |
| 2016 | 68 | 48 | 116 |
| 2017 | 53 | 63 | 116 |
| 2018 | 45 | 55 | 100 |
| 2019 | 52 | 41 | 93 |
| 2020 | 51 | 59 | 110 |
| 2021 | 38 | 46 | 84 |
| 2022 | 4 | 43 | 47 |
| 2023 | 12 | 50 | 62 |
| 2024 | 16 | 20 | 36 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Immunosuppressive Agents" by people in Profiles.
-
Association Between Early Immunosuppression Center Variability and One-Year Outcomes After Pediatric Liver Transplant. Pediatr Transplant. 2025 Feb; 29(1):e70018.
-
Association between immunosuppressive medications and COVID-19 hospitalisation and death: a retrospective cohort study. BMJ Open. 2024 Dec 26; 14(12):e087467.
-
Landscape of TPMT and NUDT15 Pharmacogenetic Variation in a Cohort of Canadian Pediatric Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2024 Dec 05; 30(12):2418-2427.
-
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS. Lupus Sci Med. 2024 Nov 09; 11(2).
-
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation. Curr Opin Nephrol Hypertens. 2025 Jan 01; 34(1):4-15.
-
Evaluation of Effective Half-Life and Its Impact on Time to Steady State for Oral MeltDose Tacrolimus (LCPT) in De Novo Kidney Transplant Recipients. Ther Drug Monit. 2025 Feb 01; 47(1):169-173.
-
Systemic Therapy for Atopic Dermatitis in Children and Adolescents: A US Expert Consensus. Dermatology. 2024; 240(5-6):897-909.
-
Recombinant Zoster Vaccination Among US Veterans Receiving Immunosuppressive Medications. JAMA Netw Open. 2024 Oct 01; 7(10):e2439945.
-
Presumptive motor neuron degeneration in an adult cat. Can Vet J. 2024 Oct; 65(10):1034-1040.
-
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Ann Rheum Dis. 2024 Sep 30; 83(10):1295-1303.